US Broker Ratings

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 10.28% Upside in the Healthcare Information Sector

Doximity, Inc. (NYSE: DOCS) stands as a prominent player within the healthcare information services industry, offering a specialized digital platform that caters to medical professionals across the United States. With..

Prestige Consumer Healthcare (PBH) Stock Analysis: 18.92% Potential Upside Amid Solid Performance

Prestige Consumer Healthcare Inc. (PBH), a key player in the healthcare sector, is garnering attention from investors due to its robust performance and significant growth potential. With a market capitalization..

DaVita Inc. (DVA) Stock Analysis: Navigating a 15.9% Upside Amidst a Shifting Healthcare Landscape

DaVita Inc. (NYSE: DVA) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $10.47 billion, DaVita is a..

The Ensign Group, Inc. (ENSG) Stock Analysis: Unveiling a 12.9% Potential Upside for Healthcare Investors

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, operates within the medical care facilities industry in the United States. With a market capitalization of $8.76..

Elanco Animal Health (ELAN) Stock Analysis: Potential 16% Upside Amid Strong Analyst Ratings

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a significant player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic animal health products. With..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a Robust Revenue Growth of 42.20%

Oscar Health, Inc. (OSCR), a key player in the healthcare plans industry, is drawing attention from investors with its impressive revenue growth of 42.20%, despite the challenges reflected in its..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: A 65% Upside Potential with Strong Buy Ratings

BioMarin Pharmaceutical Inc. (BMRN), a key player in the biotechnology sector, is garnering significant attention from investors due to its promising upside potential. With a market capitalization of $11.15 billion,..

Nuvalent, Inc. (NUVL) Stock Analysis: Biotechnology Innovator with 50.85% Potential Upside

Nuvalent, Inc. (NASDAQ: NUVL) is catching the attention of investors with its promising potential in the biotechnology sector. With a market capitalization of $5.58 billion, this clinical-stage biopharmaceutical company is..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a 18.95% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the medical devices industry, is currently drawing attention from investors with its healthcare innovations and a notable potential upside of..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with 18% Upside Potential

TransMedics Group, Inc. (NASDAQ: TMDX), a trailblazer in the healthcare sector, is capturing the attention of investors with its cutting-edge medical devices that are transforming organ transplant therapies. With a..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring the 40.84% Potential Upside for Investors

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a dynamic player in the biotechnology sector, is commanding attention with its potential for substantial returns. With a market capitalization of $6.71 billion, this U.S.-based..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 23.10% Potential Upside with Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $5.02 billion, this Utah-based company..

Legend Biotech Corporation (LEGN) Stock Analysis: Unraveling the 96.62% Potential Upside in Biotech Innovation

Legend Biotech Corporation (NASDAQ: LEGN) is making waves in the biotechnology sector with its promising pipeline of innovative therapies and a substantial market capitalization of $7.14 billion. As a key..

Charles River Laboratories (CRL) Stock Analysis: Navigating Challenges in the Healthcare Sector

Charles River Laboratories International, Inc. (NYSE: CRL), a prominent player in the healthcare sector’s Diagnostics & Research industry, faces a mixed landscape as it navigates current market conditions. With a..

Cytokinetics, Inc. (CYTK) Stock Analysis: Biotech Potential with 96.53% Upside

Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical innovator headquartered in South San Francisco, California, is making waves in the healthcare sector with its groundbreaking focus on muscle activators and inhibitors. As..

Akero Therapeutics (AKRO) Stock Analysis: 57.74% Potential Upside Captivates Investors

Akero Therapeutics, Inc. (NASDAQ: AKRO), a promising player in the biotechnology sector, is capturing investor attention with a substantial potential upside of 57.74%. Specializing in the development of treatments for..

Corcept Therapeutics (CORT): Uncovering a 94.93% Upside Potential in Biotechnology

Corcept Therapeutics Incorporated (CORT) stands out in the biotechnology sector with a compelling investment narrative, driven by its innovative drug development pipeline and significant upside potential. As a U.S.-based company..

BrightSpring Health Services, I (BTSG) Stock Analysis: An Impressive 43.41% Potential Upside for Investors

BrightSpring Health Services, Inc. (BTSG) is catching the eye of investors with its robust growth potential. Operating in the healthcare sector, specifically within the Health Information Services industry, BrightSpring is..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 5.27% Potential Upside in the Health Information Services Sector

Veeva Systems Inc. (NYSE: VEEV) stands as a prominent player in the healthcare sector, specifically within the health information services industry. With a robust market capitalization of $45.98 billion, the..

Soleno Therapeutics, Inc. (SLNO) Investor Outlook: Exploring the 33% Upside Potential in Biotech

Soleno Therapeutics, Inc. (NASDAQ: SLNO) has caught the attention of investors recently, not just for its promising therapeutic developments but also for its notable potential upside. With analyst ratings revealing..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds